Financials

News Ideas Discussions Technicals Seasonals

SONA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Sona Nanotech, Inc. engages in the development of multiple proprietary methods for the manufacture of various types of gold nanoparticles in medical applications. It is involved in developing targeted hyperthermia, a photothermal cancer therapy, which uses therapeutic heat to treat solid cancer tumors. The company was founded by Gerrard Marangoni, Kulbir Singh, and Michael McAlduff on November 17, 2004 and is headquartered in Halifax, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

SONA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company